Abeona Therapeutics Inc RPE

¿Qué es el RPE de Abeona Therapeutics Inc?

El RPE de Abeona Therapeutics Inc es $0.00

¿Cuál es la definición de RPE?

Ingresos por empleado (RPE) son ingresos divididos por el número de empleados de una organización.

RPE de compañías en Sector Health Care en NASDAQ en comparadas con Abeona Therapeutics Inc

¿Qué hace Abeona Therapeutics Inc?

abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t

Empresas con rpe similar a Abeona Therapeutics Inc